Patent · US Active

Smart dosing for cancer therapy

US12009109B2 · kind B2 · utility

1Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2020
Grant dateJun 11, 2024
Priority date
Expiry dateMay 31, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16H70/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of dosing cancer therapies, by collecting patient data including cancer therapies/drugs to be taken, analyzing the data in view of dosing criteria established based on outside data, and determining a dose for each cancer therapy/drug taken. A logic engine for dosing cancer therapies, including an algorithm stored on non-transitory computer readable media for collecting clinical trial data to establish criteria for dosing cancer therapies/drugs to a single patient and patient data and storing the clinical trial data and patient data in a database, analyzing the patient data in view of criteria established from the clinical trial data, and determining a dose for each cancer therapy/drug. A method of adjusting treatment of a cancer patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.